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Renal cell carcinoma (RCC) is one of the most frequent urological malignancies in adults. RCC often metastasizes to
other organs, but rarely to the oromaxillofacial region. Metastatic tumors to the jaws are also unusual. In this report,
we present two cases of RCC metastasis to the jaws. Metastatic RCC is resistant to radiotherapy and chemotherapy,
so surgery is the primary therapeutic choice. This report describes the diagnostic procedures utilized and the
therapeutic process in the two cases. The differential diagnosis and treatment methods are discussed.
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Jawbone metastases are rare; they account for less than 1%
of oral and maxillofacial malignancies. The most common
malignant primary lesions that metastasize to the jawbones
arise from the lung, kidney, prostate and rectum in men
and from the breast, kidney, uterus and thyroid in women.
The mandibular body and ramus are common sites of me-
tastases, and maxillary metastases are uncommon.
Adult renal cell carcinoma (RCC) is a neoplasm of the
urinary system that accounts for 3% of adult malignan-
cies and 90% to 95% of kidney tumors [1]. RCC is most
common in men ages 50 to 60 years old [2]. Only 10%
of the patients exhibit the classic Grawitz triad (flank
pain, palpable mass and hematuria) [3-5]. Thirty percent
of patients have a distant metastasis [6,7], most com-
monly to the lung, followed by bone, liver, brain and re-
gional lymph nodes, but seldom to the mandible or the
maxilla. In this report, we describe the cases of two pa-
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unless otherwise stated.pain during chewing of 1 month’s duration. A mass in the
right mandibular body measuring approximately 4.0 ×
3.0 × 2.5 cm with a clear border was visible. The buccal
bony plate of the mandible had no table tennis sense, but
the lingual bony plate was destroyed and the mass bulged
out. The texture of the mass was soft, and there was right
lower lip paresthesia. An X-ray examination revealed an
intraosseous mass with lytic damage of the right mandibu-
lar body (Figure 1). The patient’s right kidney had been re-
moved 2 years prior for RCC, and he had been receiving
200 million units of interleukin2 every week since the
operation to the presentation time. When the patient was
admitted, metastatic cancer was not initially consid-
ered;a primary tumor was favored. Metastatic RCC to
the mandible was confirmed following biopsy. Under
the microscope, we saw that the tumor cells were lar-
geand cuboidal, with some columnar, and that most of
the cancer cells in the cytoplasm were transparent.
Cellular atypia and mitosis were visible. The interstitial
tissues were rich in capillaries. Immunohistochemical
staining showed that the tumor was CAM5.2+, renal
cell carcinoma marker–positive (RCC-Ma+), CD10+,
vimentin-positive (VIM+) and Ki67+ .Patient 2
A 60-year-old man with a 4-year history of RCC of the left
kidney presented the department of stomatology, Tianjin
Medical University General Hospital with a slowly grow-
ing mass in the maxilla of 20 days’ duration. The mass
was located at the palatal side of the anterior teeth andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Case 1: renal cell carcinoma metastasis to the mandible. (a) Photograph showsswelling of the right side of the patient’s jaw due to
the mandibular tumor. (b) Radiograph showsosteolytic damage in the right mandibular body. (c) Hematoxylin and eosin–stained tumor section.
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lar outline. The surface was ulcerated, with an overlying
pseudomembranous layer and hemorrhage. A computed
tomography scan showed lytic destruction of the alveolar
bone (Figure 2). The patient had been noted to have a lung
metastasis 2 months earlier. In contrast to case 1, a diagno-
sis of metastatic RCC was readily made on the basis of the
presence of existing systemic metastases. The tumor was
resected later. Expansion of the blood vessels,along with
bleeding and a hemosiderin deposit,were seen under the
microscope. Cellular atypia and mitosis were visible, the
tumor cells were largeand the cytoplasm was transparent.
Immunohistochemical staining showed that the tumor was
CAM5.2+, RCC-Ma+, CD10+, VIM+ and Ki67+ .Figure 2 Case 2: renal cell carcinoma metastasis to the maxilla. (a) Ph
tomography scan shows the osteolytic damage in the maxilla. (c) HematoxDifferential diagnosis
Malignant tumors of the jaw can cause lip paresthesia,
numbness, jaw swelling, pain and tooth mobility. These
symptoms are often persistent and progressive. X-rays typ-
ically show irregular osteolytic destruction.
Oral and maxillofacial surgeons should distinguish jaw
metastases of RCC from central mandibular carcinoma,
squamous cell cancer, carcinoma arising from salivary
glands (such as mucoepidermoid, myoepithelial, epithelial–
myoepithelial and acinar cell carcinoma) and benign gum
diseases (such as epulis). Metastases also should be differ-
entiated from other primary clear-cell tumors, which are
odontogenic or gland-derived. Consequently, the identifica-
tion of mandibular metastatic RCC is relatively difficult andotograph shows the patient’s maxillary tumor. (b) Computed
ylin and eosin–stained tumor section.
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history of primary RCC is crucial to making a definitive
diagnosis. If the jaw tumor has a rich blood supply and the
patienthas a history of RCC, then metastatic RCC should
be considered in the differential diagnosis.
Treatment
A biopsy was performed for patient 1to confirm the diag-
nosis. The patient had severe bleeding during surgery.
Hemorrhage continued despite the use of hemostatic
agents, suture hemostasis and adrenaline package oppres-
sion. The bleeding was controlled by tightly packing the
tumor bone cavity with gauze. The patient required a
1,000-ml whole-blood transfusion. He refused follow-up
segmental resection of the mandible after receiving his
diagnosis. He was referred to the oncology department for
palliative care.
Patient 2 underwent complete curettage of the metastatic
tumor with additional resection of the surrounding alveolar
process. Although the patient had severe hemorrhage dur-
ing surgery, the bleeding was relatively easy to control be-
cause of the relatively superficial location of the metastasis.
The patient’s hemoglobin remained within the normal
range following surgery, and he thus did not require trans-
fusion. Follow-up interferon therapy was administered.
RCC has a propensity to metastasize to another organs,
including bilateral adrenal glands [8], skin [9,10], pancreas
and spleen [11], gastric or duodenal systems [12], skeleton
[13], pancreas [14] and bladder [15,16]. However, metasta-
ses from RCC rarely affect the head and neck region [17].
Metastatic RCC is resistant to radiotherapy and chemo-
therapy, so supportive care and surgery remain the princi-
pal treatments of metastatic disease [6]. If the primary
tumor has been or can be excised, then metastatic lesions
in the jaws should be resected. The risk of hemorrhage is
high in these cases, and preoperative vascular embolization
to reduce bleeding is recommended [18-20].
The mandibular metastasis case reported in this article
was not considered to be a metastatic cancer at the time
of patient admission, because the tumor clinically mim-
icked other localized hyperplasic lesions of the jaw. Patient
1 underwent biopsy and surgery, with resultant intraoper-
ative bleeding similar to the central hemangioma of the
mandible. The tumor in the transferred maxillarycarci-
noma patient was initially considered to have a metastatic
RCC focus. The location of the tumor was relatively super-
ficial and the operative field broad, so intraoperative bleed-
ing was easy to control.
Conclusions
Metastases from internal neoplasms should be consid-
ered among other differential diagnoses in the evaluation
of jaw tumors. Especially for patients with a history of
RCC, the possibility of metastatic disease should not beignored. Because jaw metastases of RCC have an exten-
sive supplementary blood supply, appropriate prepar-
ation to prevent the risk of bleeding is required prior to
biopsy and definitive surgery.
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